Neurostimulation shines a light on dopamine brain circuits
Stimulating dopamine neurons in adolescent mice rescued cognitive deficits associated with future development of neuropsychiatric disorders.
schizophrenia
After 70 years, a new class of drugs for schizophrenia
A new type of drug for schizophrenia could finally be approved in September. Others may not be far behind.
No more daily pills: A new star in long-acting drug delivery
With a star-shaped drug delivery platform that can stay in the stomach for a week or more, researchers hope to improve medication compliance and overall health.
The potential placental origins of schizophrenia
Researchers identified schizophrenia risk genes that mediate placental, rather than brain, function, revealing new insight into the disease’s developmental origins.
A worldwide effort to bank patient DNA
Researchers around the world are on a mission to bank biological samples from millions of people. So far, these efforts have disclosed the effects of arsenic exposure on the genome, supported development of early cancer diagnostics, and even revealed the ideal timing for COVID-19 boosters.
A promising new class of psychotropic drugs
A newly developed drug stabilizes dopamine and serotonin levels using a novel mechanism. It effectively treats psychosis in patients with schizophrenia, and researchers are testing its efficacy for Parkinson’s disease as well.
The easy way in
Wide adoption and regimen compliance are two reasons for easier administration, whether with COVID or schizophrenia
